Abbott Boosts 2026 Profit Guidance as Sales Across Business Rise
Bloomberg 2026-07-16 11:41:45
Context: Abbott Laboratories has increased its 2026 profit guidance following a stronger-than-expected second quarter. The company's improved performance was driven by gains across most of its business lines. This upward revision comes as the company experiences a positive trend in its sales.
Key Facts
- Abbott Laboratories raised its 2026 profit guidance due to a stronger-than-expected second quarter performance.
- The company's improved performance was driven by enhanced results across most of its business lines.
- The upward revision of the 2026 profit guidance reflects a positive trend in the company's sales.